GlassScriptPhysician profile
Antonio Jimenez
NPI 1093034084
$16,334.82
in general payments reported to CMS, 2019-2025
15 companies · $276 in 2025
The $276 reported for 2025 was less than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $379 · 2020: $675 · 2021: $2,297 · 2022: $6,151 · 2023: $2,425 · 2024: $4,132 · 2025: $276.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,908 · Food and Beverage: $1,925.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,907.83 |
| Food and Beverage | $1,925.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $7,171.98 | 2022-2025 | Venaseal, Ellipsys Vascular Access System, Closurefast |
| Bard Peripheral Vascular, INC. | $7,028.74 | 2020-2023 | Venclose Maven Catheter |
| Astrazeneca Pharmaceuticals LP | $532.98 | 2019-2025 | Lokelma, Farxiga |
| Mallinckrodt Hospital Products INC. | $491.63 | 2021-2023 | Acthar |
| Becton, Dickinson and Company | $205.22 | 2023 | Pristine |
| Bayer Healthcare Pharmaceuticals INC. | $202.11 | 2022-2023 | |
| Nxstage Medical, INC. | $160.43 | 2023 | Nxstage System One |
| Mallinckrodt Enterprises LLC | $125.00 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $125.00 | 2023 | Jynarque |
| Glaxosmithkline, LLC. | $77.39 | 2022 | |
| Janssen Pharmaceuticals, INC | $61.11 | 2019 | |
| Calliditas Therapeutics US INC. | $59.69 | 2023 | Tarpeyo |
| Bayer Puerto Rico INC. | $46.01 | 2023 | Kerendia |
| Bard Access Systems, INC. | $41.18 | 2019 | |
| Akebia Therapeutics INC | $6.35 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Antonio Jimenez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.